The possibility to make virtually all cell types of the human body from induced pluripotent stem cells (iPSCs), which are embryonic-like cells generated from a patient's skin, in a process called reprogramming, has opened ...
Sep 22, 2022
0
99
A recent study in the Journal of Investigative Dermatology describes the success of using lenabasum, a cannabinoid receptor type 2 (CB2) agonist that triggers the resolution of inflammation, to treat amyopathic dermatomyositis. ...
Sep 21, 2022
0
2
A biologic therapy for very young children with a moderate to severe form of a common skin condition has been shown to be safe and effective in an international trial which involved University of Manchester clinical scientists ...
Sep 15, 2022
0
1242
An experimental drug that has been shown to treat rashes in people with lupus may also help with lupus-related joint pain.
Sep 8, 2022
0
4
A newly funded Tropical Medicine Research Center at The Ohio State University will study factors that drive transmission and spread of visceral leishmaniasis, a serious parasitic disease in Eastern Africa that is fatal without ...
Sep 7, 2022
0
6
Researchers have identified an immune biomarker in newborns that can predict the subsequent onset and severity of pediatric atopic eczema, a new study presented at the 31st European Academy of Dermatology and Venereology ...
Sep 7, 2022
0
4
People with light skin tones are far more likely to develop melanoma skin cancer than people with dark skin tones. This large disparity results from far more than can be explained by the UV protective effects of melanin pigment, ...
Sep 6, 2022
0
128
The disease burden attributable to nonmelanoma skin cancer (NMSC) is considerable and expected to continue increasing, according to a study published online July 30 in BMC Cancer.
Sep 1, 2022
0
7
Pakistani health officials on Thursday reported an outbreak of waterborne diseases in areas hit by recent record-breaking flooding, as authorities stepped up efforts to ensure the provision of clean drinking water to hundreds ...
Sep 1, 2022
0
7
A UC Davis Health study finds that the antiviral tecovirimat appears to be safe and effective for the treatment of monkeypox symptoms and skin lesions. The study is one of the earliest studies to assess and report the outcomes ...
Aug 26, 2022
0
33
